搜尋結果
US FDA approves Neurocrine Biosciences' movement disorder drug
Reuters· 17 小時前, opens new tab Ingrezza drug to treat movement disorders associated with Huntington's disease (HD), the company said on ...
Coinbase posts soaring profit on jump in crypto prices
Reuters· 6 小時前, opens new tab swung to a first-quarter profit of over $1 billion from a year earlier loss, ...
US Senate approves bill to ban Russian uranium imports
Reuters· 2 日前The U.S. Senate approved on Tuesday legislation to bar imports of Russian uranium, ...
Black Startups From The Pandemic Boom Now Struggle to Access Capital
Bloomberg· 17 小時前Have a confidential tip for our reporters? Three years after pandemic-era funding led to a boom ...
Furor Over The SEC’s Delayed ESG “Scope 3” Emissions Rule Is Misplaced
Forbes· 2 日前The 3-2 vote by the SEC in March to approve a subset of such requirements for its ...
Russia’s Posting More To TikTok — And Seeing Greater Engagement With Its Posts, Report Says
Forbes· 23 小時前Since 2022, the number of Russian state-affiliated accounts, many of which are labeled ... ...
FDA approves Pfizer’s first gene therapy for rare inherited bleeding disorder
CNBC· 7 日前The Food and Drug Administration on Friday announced that the agency approved Pfizer's ...
Dengue sparks concern in Latin America
China Daily· 1 日前The dengue outbreak across Latin America has reached alarming levels with reported cases already surpassing 5.2 million ...
InnovationRx: FDA Approves Abbott’s Dissolvable Stents
Forbes· 2 日前When this disease impacts the lower legs, the standard of care is balloon angioplasty, which can be helpful ...
Is Chipotle Stock A Buy Ahead Of Its Large 50-For-1 Stock Split?
Forbes· 3 日前With the Chipotle stock trading at all-time highs, the stock split seems like a welcome move as ...